NEOONSITE
DEAD

Serial Number

79211994

Owner

SIEMENS HEALTHCARE GMBH

Attorney

Karla M. Weyand

Filing Date

Jan 25, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEOONSITE Trademark

Serial Number: 79211994 • Registration: 5372317

NEOONSITE is a trademark filed by SIEMENS HEALTHCARE GMBH on January 25, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SIEMENS HEALTHCARE GMBH (383 trademarks)

Munchen 80333 , DE

Entity Type: 03

Trademark Details

Filing Date

January 25, 2017

Registration Date

January 9, 2018

Published for Opposition

October 24, 2017

Cancellation Date

July 26, 2024

Goods & Services

Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; * diagnostic preparations for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases * [ diagnostic preparations for medical purposes ] ; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection [, ] * and * analysis [ and treatment ] of cancer; cultures of microorganisms for medical and veterinary use *, namely, for the identification [, ] * and * analysis [ and treatment ] of cancer and cancerous diseases *

Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases

Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jul 11, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 21, 2025 INTS
INVALIDATION PROCESSED
Jun 21, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 26, 2025 INTR
CANCELLED SECTION 71
Jul 26, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 9, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 24, 2021 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 3, 2019 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 13, 2019 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Mar 6, 2019 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 6, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 6, 2019 APRE
LIMITATION OF GOODS RECEIVED FROM IB
Nov 16, 2018 LIMG
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 5, 2018 COC.
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 3, 2018 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Aug 31, 2018 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
May 25, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 17, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 17, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Oct 21, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2017 CRFA
ASSIGNED TO LIE
Aug 29, 2017 ALIE
REFUSAL PROCESSED BY IB
Aug 25, 2017 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 10, 2017 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2017 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 4, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 3, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 1, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 31, 2017 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jul 26, 2017 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 18, 2017 MAFR
ASSIGNED TO EXAMINER
Jul 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 13, 2017 REPR